Health condition
Adult metachromatic leukodystrophy
Adult-onset metachromatic leukodystrophy typically begins with psychiatric or behavioural change and slipping performance - a genetic white matter disease whose recognition matters for family counselling and emerging treatment.
Key points
What matters most, at a glance.
The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.
-
Adult MLD often starts psychiatrically: personality change, disinhibition, poor judgement, psychosis - years before motor signs
-
Cognitive decline with frontal features and eventual spasticity, ataxia and neuropathy follow
-
MRI: symmetric confluent white matter change with sparing of U-fibres, frontally weighted in adults
-
Diagnosis: low arylsulfatase A activity plus urinary sulfatides and ARSA gene testing - pseudodeficiency must be excluded
-
Gene therapy has transformed early childhood MLD; adult treatment remains largely supportive with trials evolving
-
Sibling testing and genetic counselling are integral - presymptomatic relatives have the most options
Understanding it
About Adult metachromatic leukodystrophy, and what to do next.
MLD is a lysosomal disorder - failing arylsulfatase A lets sulfatides poison myelin - and its adult-onset form (the mildest allele combinations) opens with the brain's frontal networks: a competent adult becomes erratic, disorganised, socially inappropriate or psychotic, and years may pass inside psychiatric services before an MRI reveals symmetric white matter disease of a pattern no psychiatric illness produces. Motor decline, spasticity and peripheral neuropathy arrive later, and the illness runs over years to decades.
Diagnosis needs biochemical care: low ARSA enzyme activity is necessary but insufficient, because harmless pseudodeficiency alleles are common - urinary sulfatide measurement and ARSA sequencing complete the proof. The therapeutic landscape is split by age: gene therapy now treats pre- and early-symptomatic childhood MLD with striking results, while established adult disease is managed supportively - psychiatric care, spasticity and swallowing management, planning support - with transplant and gene-based approaches for adults still matters of research and case-by-case specialist judgement. That asymmetry is exactly why family work is urgent: identifying a presymptomatic sibling or relative converts a tragedy into a decision point. Leukodystrophy specialist centres and patient organisations carry both the expertise and the trial map.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them.
Frequently asked
Common questions about Adult metachromatic leukodystrophy.
Quick, plain-English answers to what people ask us most.
-
What is adult metachromatic leukodystrophy?
Adult metachromatic leukodystrophy is a rare inherited metabolic disorder causing progressive damage to the protective myelin coating of nerves in the brain and nervous system, leading to gradual neurological and psychiatric decline.
-
What causes metachromatic leukodystrophy?
It is caused by a deficiency of the enzyme arylsulfatase A, leading to a build-up of fatty substances (sulfatides) that damage the myelin sheath surrounding nerve cells.
-
What are the symptoms of adult-onset metachromatic leukodystrophy?
Symptoms often begin with subtle personality or behavioural changes, cognitive decline, and psychiatric symptoms, progressing to movement difficulties, muscle stiffness, and eventually more significant physical and cognitive impairment.
-
Is metachromatic leukodystrophy dangerous?
Yes, it is a progressive, life-limiting condition, though the adult-onset form generally progresses more slowly than the infantile or juvenile forms, allowing a longer period of relatively preserved function.
-
Is metachromatic leukodystrophy genetic?
Yes, it is an autosomal recessive condition, meaning it requires an altered gene copy from both parents, who are typically unaffected carriers themselves.
-
Can metachromatic leukodystrophy be cured?
There is no cure for established adult-onset disease, though stem cell transplant may help slow progression in some cases if performed relatively early, and supportive care can help manage symptoms.
-
How is adult metachromatic leukodystrophy managed?
Management focuses on supportive care including physiotherapy, symptom management for movement and psychiatric symptoms, and in select cases, consideration of stem cell transplantation at specialist centres.
-
How does the adult form differ in progression from childhood forms?
The adult-onset form typically progresses more slowly over years, often starting with psychiatric or cognitive changes rather than the more rapid, predominantly physical decline seen in infantile forms.
-
Adult metachromatic leukodystrophy vs other adult-onset leukodystrophies — what's the difference?
Metachromatic leukodystrophy is specifically caused by arylsulfatase A deficiency and confirmed by enzyme and genetic testing, distinguishing it from other leukodystrophies which involve different enzyme deficiencies or genetic causes, even though initial symptoms can overlap.
-
When should I see a doctor about possible adult-onset leukodystrophy, and how quickly can I be seen privately?
See a doctor for unexplained progressive cognitive, psychiatric, or movement changes, particularly with a relevant family history. NHS neurology referral can take many weeks, while private specialist assessment is often available within about two weeks.